While both regulate IGF activity, IGFBP-3 predominantly acts as a tumor suppressor by inhibiting IGF-1 and IGF-2 from activating IGF-1R, thus reducing cell proliferation and promoting apoptosis. The gene discussed is IGFBP3; the disease is neoplasm.